Oracle Corp faces securities fraud lawsuit following 11% stock decline

ider of cloud infrastructure. Oracle is now more focused on offering cloud computing infrastructure for advanced AI models. The lawsuit claims that Oracle misled investors by highlighting data center development contracts to construct AI infrastructure while falsely assuring investors that their substantial CapEx investment in AI would result in rapid revenue and profit growth. However, the lawsuit alleges that Oracle’s AI strategy significantly increased CapEx without generating meaningful near-term revenue, which could endanger Oracle’s debt, credit rating, and ability to fund projects.

The lawsuit against Oracle stems from a series of disclosures made in September and December 2025. Notably, on December 10, 2025, Oracle reported that its second-quarter revenue growth was below analyst expectations, CapEx exceeded analysts’ forecasts, and negative free cash flow was over $10 billion. Despite the increased spending, Oracle did not raise its revenue projections for 2026 and only increased its 2027 revenue projections by $4 billion. This news led to a substantial drop in Oracle’s stock price, decreasing by nearly 11%.

Investors who believe they have been impacted by Oracle’s alleged securities fraud have until April 6, 2026, to pursue legal action. The lawsuit claims violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Oracle investors. The case is ongoing in the U.S. District Court for the District of Delaware under the title Barrows v. Oracle Corporation, et al., No. 1:26-cv-00127.

Bleichmar Fonti & Auld LLP, the leading securities law firm behind the lawsuit, specializes in representing plaintiffs in securities class actions and shareholder litigation. The firm has been recognized as a top plaintiff law firm by various legal authorities. Notable successes include recovering over $900 million from Tesla, Inc.’s Board of Directors and $420 million from Teva Pharmaceutical Ind. Ltd. Investors who have questions or believe they may have a legal case against Oracle are encouraged to submit their information to Bleichmar Fonti & Auld LLP for further review. The firm operates on a contingency fee basis, meaning there are no costs to shareholders upfront. Shareholders will not be responsible for any court fees or litigation expenses.

For further information about Bleichmar Fonti & Auld LLP and its team of attorneys, interested parties can visit their official website. Brining a claim against a corporation for securities fraud is a daunting but necessary step to hold companies accountable for potentially misleading practices in the eyes of the law.